Safety Pharmacology for the 21st Century – new technologies and approaches supporting safety and predictivity within drug discovery and development
-
Chair(s):
Helen Prior
Programme Manager, Drug Development,National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs), London, United Kingdom ,Andrea Greiter-Wilke
SPS Vice President Elect, Roche, Switzerland -
Session description:
Advances in Safety Pharmacology for improved risk assessment and translation of cardiovascular and CNS adverse events
Andrea Greiter-Wilke
SPS Vice President Elect, Roche, SwitzerlandInnovative models for in vitro detection of seizure
Dr Kimberley Rockley
Research Fellow, ApconiX, Alderley Edge, United KingdomOral communication speaker to be confirmed in 2023.
Use of computational approaches to identify cardiotoxicity risk
Maxx Holmes
Oxford University, United KingdomIntegration of multiple endpoints into the same animal model or toxicology studies
Henk van der Linde
Principal Scientist, Janssen, Global Toxicology and Safety Pharmacology
Speakers
-
Andrea Greiter-WilkeSPS Vice President Elect, Roche, Switzerland
-
Dr Francesca PibiriJ&J Belgium, Beers, Belgium
-
Dr Kimberley RockleyResearch Fellow, ApconiX, Alderley Edge, United Kingdom
-
Henk van der LindePrincipal Scientist, Janseen Pharmaceutical Company, Berlin
-
Maxx HolmesUniversity of Oxford, UK
Leave A Comment